Decabromodiphenyl ether causes insulin resistance and glucose and lipid metabolism disorders in mice

doi:10.4239/wjd.v12.i8.1267

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 8

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4242)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-10) series, Tables (1-5) series.

Item

Count

PDF

355

WORD

125

HTML

1930

Figures (1-10)

179

Tables (1-5)

352

Sum=2941

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

489

Download

812

Sum=1301

Aug 15, 2021 (publication date) through Jul 25, 2024

Times Cited of This Article

Times Cited (10)

Journal Information of This Article

Publication Name

World Journal of Diabetes

ISSN

1948-9358

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Diabetes. Aug 15, 2021; 12(8): 1267-1281
Published online Aug 15, 2021. doi: 10.4239/wjd.v12.i8.1267

Full Size Figure Download Figure

Figure 9 Comparison of leptin protein expression in adipose tissue of mice in each group. A: Quantification of the data presented in B; B: Immunoblots of each group. ^aP < 0.05 compared with the control group; ^bP < 0.05 compared with the medium dose group; and ^cP < 0.05 compared with the low dose group. H: High dose group; MH: Medium-high dose group; M: Medium dose group; ML: Medium-low dose group; L: Low dose group; C: Control group.

Citation: Alimu A, Abudureman H, Wang YZ, Li MY, Wang JS, Liu ZL. Decabromodiphenyl ether causes insulin resistance and glucose and lipid metabolism disorders in mice. World J Diabetes 2021; 12(8): 1267-1281
URL: https://www.wjgnet.com/1948-9358/full/v12/i8/1267.htm
DOI: https://dx.doi.org/10.4239/wjd.v12.i8.1267